Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|July 6, 2020
Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myelomaTan-Huy Chu, Manh-Cuong Vo, Hye-Seong Park, et al.
Oncotarget|May 3, 2017
Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer modelManh-Cuong Vo, Thanh-Nhan Nguyen-Pham, Hyun-Ju Lee, et al.
Experimental Hematology|November 28, 2016
Lenalidomide enhances the function of dendritic cells generated from patients with multiple myelomaManh-Cuong Vo, Truc Anh-NguyenThi, Hyun-Ju Lee, et al.
Frontiers in Immunology|August 21, 2018
Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma ModelManh-Cuong Vo, Seoyun Yang, Sung-Hoon Jung, et al.
Frontiers in Immunology|July 4, 2018
Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine MyelomaManh-Cuong Vo, Sung-Hoon Jung, Tan-Huy Chu, et al.
The Korean Journal of Internal Medicine|February 14, 2019
Cellular immunotherapy in multiple myelomaManh-Cuong Vo, Thangaraj Jaya Lakshmi, Sung-Hoon Jung, et al.
Translational Oncology|April 12, 2022
Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myelomaTan-Huy Chu, Manh-Cuong Vo, Thangaraj Jaya Lakshmi, et al.
Pageof 1